Lepu Biopharma Co. Ltd. Class H's total assets for Q2 2025 were ¥2.36B, an increase of 3.55% from the previous quarter. HK:2157 total liabilities were ¥1.65B for the fiscal quarter, a 3.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.